Unspecified [23-005143]
Active Awarded Last action
- Contract number
- 75N95023F00002
- Awardee
-
New York Genome Center, Inc. UEI WKPTJDWG2C68
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $22,689,037
Award facts
- Opportunity
-
- 75N95023R00038 Solicitation number
- Contract value 32% obligated
-
- $22,689,037.47 Current, with exercised options
- $69,863,315.47 Potential, with all options
- Completion date 68% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- New York, NY 10013, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $8,733,654 | |
| Funding Only Action | -$12,687,372 | |
| Exercise an Option | $8,701,678 | |
| Exercise an Option | $8,985,317 | |
| Original award | $8,955,760 |
About this award
The National Institute on Drug Abuse issued a delivery order to New York Genome Center, Inc. on May 29, 2023, under the BRAIN Initiative Cell Atlas Network (BICAN) Sequencing Core Indefinite Delivery Contract, with a ceiling value of $69.86 million and an ultimate completion date of May 28, 2028.
Place of performance is New York, NY. The order is priced on a cost no-fee basis and funds BICAN sequencing services for the Cell Atlas Network research initiative. In fiscal year 2024, the order invoiced $3.8 million across 1.9 FTEs and 3,869 contractor hours, yielding a derived government-paid hourly rate of $982.63 per hour. New York Genome Center self-performed all reported hours with no subcontractor engagement.
Quick answers
Who was awarded contract 75N95023F00002?
75N95023F00002 was awarded to New York Genome Center, Inc. by National Institute on Drug Abuse (National Institutes of Health) on May 29, 2023.
How much is contract 75N95023F00002 worth?
The government has obligated $22,689,037 on 75N95023F00002. Its potential value, with all options, is $69,863,315.
Is contract 75N95023F00002 an order under another contract?
Yes. 75N95023F00002 is a delivery order under 75N95023D00007, an indefinite delivery contract, on BRAIN Initiative Cell Atlas Network (BICAN) Sequencing Core.
Was contract 75N95023F00002 competed?
The extent of competition for 75N95023F00002 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award